Basic information

Full name
protein kinase cAMP-dependent type I regulatory subunit alpha
Ensembl
ENSG00000108946.15
Summary
cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. This gene encodes one of the regulatory subunits. This protein was found to be a tissue-specific extinguisher that down-regulates the expression of seven liver genes in hepatoma x fibroblast hybrids. Mutations in this gene cause Carney complex (CNC). This gene can fuse to the RET protooncogene by gene rearrangement and form the thyroid tumor-specific chimeric oncogene known as PTC2. A nonconventional nuclear localization sequence (NLS) has been found for this protein which suggests a role in DNA replication via the protein serving as a nuclear transport protein for the second subunit of the Replication Factor C (RFC40). Several alternatively spliced transcript variants encoding two different isoforms have been observed. [provided by RefSeq, Jan 2013]
Annotation
Cancer driver (Oncogene) Cancer driver (TSG)

Protein product

Phosphosites on the primary protein product
Loading...

Tumor and normal comparison

Loading, please wait
Signed p-values
Data type
Meta P
BRCA
CCRCC
COAD
GBM
HNSCC
LSCC
LUAD
OV
PDAC
UCEC
RNA-1.8e-39--2.5e-10---1.4e-4-1.2e-31-1.3e-15-0.67-
protein-2.1e-19-1.5e-10-4.3e-31--1.1e-9-5.8e-12-3.3e-90.370.33-0.001

* P-values are from Wilcoxon rank sum test and can be clicked to show the box plots. Positive values mean higher abundance in tumor. BRCA and GBM do not have normal samples.

mRNA expression at gene level
BRCACCRCCCOADGBMHNSCCLSCCLUADOVPDACUCEC9.51010.51111.51212.51313.51414.51515.5log2(RSEM+1)tumornormal
Protein expression
BRCACCRCCCOADGBMHNSCCLSCCLUADOVPDACUCEC2525.52626.52727.52828.52929.5log2(MS1 intensity)tumornormal

* Mild outlier: filled circle; Extreme outlier: empty circle.

Phenotype and mutation association

Manhattan plot summarizing associations of phenotypes and mutations across all cohorts and omics data types

BRCACCRCCCOADGBMHNSCCLSCCLUADOVPDACUCEC02468101214160-2-4-6-8-10-12-14-16Pan-cancer024681012141618202224260-2-4-6-8-10-12-14-16-18-20-22-24-26proteinRNASCNVclinicalpathwaycell typegenomicmutation-log10 of P-value

* Data points of significant associations above and below the dotted lines can be hovered to show the phenotype.

Associations of the protein abundance of PRKAR1A with phenotypes and mutations

Loading, please wait
Signed p-values
Phenotype
Meta P
BRCA
CCRCC
COAD
GBM
HNSCC
LSCC
LUAD
OV
PDAC
UCEC
xcell: microenvironment score1.5e-176.2e-3-0.783.6e-64.0e-68.9e-36.5e-52.3e-6-0.470.0576.2e-3
PROGENy: Trail3.6e-155.3e-3-0.24.3e-33.3e-32.8e-51.0e-53.1e-4-0.773.2e-36.6e-3
ESTIMATE: ImmuneScore9.9e-152.1e-4-0.591.9e-52.3e-60.0359.8e-52.0e-50.590.310.63
ESTIMATE: ESTIMATEScore1.6e-137.5e-3-0.345.2e-52.5e-62.3e-33.0e-42.6e-5-0.510.380.076
xcell: Myeloid dendritic cell activated2.7e-130.0310.762.6e-60.392.3e-36e-84.1e-30.210.020.87
HALLMARK_ALLOGRAFT_REJECTION3.2e-132.8e-4-0.396.4e-51.6e-50.0734.3e-55.6e-50.180.27-0.68
xcell: immune score7.6e-135.6e-4-0.432.5e-52.4e-60.0926.3e-51.7e-5-0.960.18-0.83
HALLMARK_IL2_STAT5_SIGNALING8.6e-137.7e-412.0e-42.4e-50.022.5e-49.6e-4-0.770.60.54
xcell: T cell CD8+ central memory4.2e-124.2e-4-0.683.2e-50.580.0663.3e-40.0170.282.6e-50.33
xcell: B cell1e-101.1e-30.422.1e-30.0150.352.5e-44.9e-30.424.4e-3-0.84
Showing 1 to 10 of 256 rows

* P-values could be from test for Spearman correlation, Wilcoxon rank sum test, Jonckheere-Terpstra trend test or Cox regression depending on the data type. P-values for individual cohorts can be clicked to show the data plots. The matrix icons in each row can be clicked to show a heatmap summary of associations across all cohorts and omics. The rows in the table can be expanded to show results from other omics.

Cis-association

Associations between omics data of PRKAR1A

BRCA0.160.160.47proteinmRNASCNVmethylationCCRCC0.230.170.00-0.01-0.11-0.01proteinmRNASCNVmethylationCOAD0.300.110.34proteinmRNASCNVmethylationGBM0.140.120.110.140.20-0.24proteinmRNASCNVmethylationHNSCC0.180.12-0.02-0.150.02-0.14proteinmRNASCNVmethylationLSCC0.15-0.09-0.160.060.07-0.19proteinmRNASCNVmethylationLUAD0.090.100.30-0.120.390.06proteinmRNASCNVmethylationOV-0.060.170.52proteinmRNASCNVmethylationPDAC0.000.030.030.030.55-0.04proteinmRNASCNVmethylationUCEC0.350.00-0.060.040.26-0.03proteinmRNASCNVmethylation

* The numbers are Spearman correlation coefficients and can be clicked to show the scatter plots. The color and size of the circles correlate with the coefficients.

Trans-association

Associations of the protein abundance of PRKAR1A and the protein abundance of other genes

Loading, please wait
Signed p-values
Gene
Meta P
BRCA
CCRCC
COAD
GBM
HNSCC
LSCC
LUAD
OV
PDAC
UCEC
No matching records found

* P-values are from test for Spearman correlation. P-values for individual cohorts can be clicked to show the data plots. The matrix icons in each row can be clicked to show a heatmap summary of associations across all cohorts and omics. The rows in the table can be expanded to show results from other omics.

Gene set enrichment analysis

Submit genes and the common logarithm of the p-values of their association with to WebGestalt.